The University of Pennsylvania is acting proud of Katalin Karikó now that she's won a Nobel. But they kicked her out of her research assistant professor job when she insisted on doing the work that won her that prize:

"She recalls spending one Christmas and New Year’s Eve conducting experiments and writing grant applications. But many other scientists were turning away from the field, and her bosses at UPenn felt mRNA had shown itself to be impractical and she was wasting her time. They issued an ultimatum: if she wanted to continue working with mRNA she would lose her prestigious faculty position, and face a substantial pay cut.

”It was particularly horrible as that same week, I had just been diagnosed with cancer,” said Karikó. “I was facing two operations, and my husband, who had gone back to Hungary to pick up his green card, had got stranded there because of some visa issue, meaning he couldn’t come back for six months. I was really struggling, and then they told me this."

"While undergoing surgery, Karikó assessed her options. She decided to stay, accept the humiliation of being demoted, and continue to doggedly pursue the problem. This led to a chance meeting which would both change the course of her career, and that of science."

Elsewhere she recalled:

“I thought of going somewhere else, or doing something else. I also thought maybe I’m not good enough, not smart enough."

She's now an adjunct in UPenn's neurosurgery department. Will they fast-track her for tenure now that she has a Nobel, or just live with the shame?

Both quotes here come from interesting stories. The first is from here:

https://www.wired.co.uk/article/mrna-coronavirus-vaccine-pfizer-biontech

The second is from here:

https://billypenn.com/2020/12/29/university-pennsylvania-covid-vaccine-mrna-kariko-demoted-biontech-pfizer/

How mRNA went from a scientific backwater to a pandemic crusher

For decades, Katalin Karikó's work into mRNA therapeutics was overlooked by her colleagues. Now it's at the heart of the two leading coronavirus vaccines

WIRED UK

@johncarlosbaez

The nice thing is with that Nobel Prize in her pocket, she can go anywhere she wants and work with whoever she wants.
She can build a program around what she wants to do and universities will fall at her feet to make it happen now.

UPenn will be very fortunate indeed if she ever has anything to do with them again.

@michaelcoyote - indeed; she can write her own ticket now. Since 2019 was senior vice president of BioNTech RNA Pharmaceuticals, but in 2022 she left BioNTech to devote more time to research. So she obviously still wants to do research.
@johncarlosbaez Yes it seems so based on everything I've read about her.